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Abstract
Background. Schizophrenia is associated with impaired neurodevelopment as indexed by
lower premorbid IQ. We examined associations between erythrocyte sedimentation rate
(ESR), a marker of low-grade systemic inflammation, IQ, and subsequent schizophrenia
and other non-affective psychoses (ONAP) to elucidate the role of neurodevelopment and
inflammation in the pathogenesis of psychosis.
Methods. Population-based data on ESR and IQ from 638 213 Swedish men assessed during
military conscription between 1969 and 1983 were linked to National Hospital Discharge
Register for hospitalisation with schizophrenia and ONAP. The associations of ESR with
IQ (cross-sectional) and psychoses (longitudinal) were investigated using linear and Cox-
regression. The co-relative analysis was used to examine effects of shared familial confound-
ing. We examined mediation and moderation of effect between ESR and IQ on psychosis risk.
Results. Baseline IQ was associated with subsequent risk of schizophrenia (adjusted HR per 1-
point increase in IQ = 0.961; 95% confidence interval (CI) 0.960–0.963) and ONAP (adjusted
HR = 0.973; 95% CI 0.971–0.975). Higher ESR was associated with lower IQ in a dose-
response fashion. High ESR was associated with increased risk for schizophrenia (adjusted
HR = 1.14; 95% CI 1.01–1.28) and decreased risk for ONAP (adjusted HR = 0.85; 95% CI
0.74–0.96), although these effects were specific to one ESR band (7–10 mm/hr). Familial con-
founding explained ESR-IQ but not ESR-psychoses associations. IQ partly mediated the ESR-
psychosis relationships.
Conclusions. Lower IQ is associated with low-grade systemic inflammation and with an
increased risk of schizophrenia and ONAP in adulthood. Low-grade inflammation may influ-
ence schizophrenia risk by affecting neurodevelopment. Future studies should explore the dif-
ferential effects of inflammation on different types of psychosis.
Introduction
The neurodevelopmental hypothesis of schizophrenia posits that abnormal neurodevelopment
contributes to the pathogenesis of the illness (Murray & Lewis, 1987; Weinberger, 1987). This
hypothesis is supported by population-based longitudinal studies showing an association of
schizophrenia and other non-affective psychoses (ONAP) with lower IQ during childhood/
premorbid period (Jones et al. 1994; Crow et al. 1995; David et al. 1997; Davidson et al.
1999; Cannon et al. 2000, 2002; Zammit et al. 2004; Reichenberg et al. 2005; Kendler et al.
2015). These findings have been summarised in a meta-analysis, which shows that there is
a linear association between premorbid IQ and risk of adult schizophrenia and related psych-
oses; for every one-point decrease in IQ risk for schizophrenia increases by 3.7% (Khandaker
et al. 2011).
Co-relative control analysis is a way to examine familial confounding. This approach com-
pares effect sizes for a particular risk factor-disease association between the general population
and groups of relatives with different levels of relatedness (i.e. full siblings, half-siblings, cou-
sins). If the effect size decreases in groups of relatives, compared with general population, this
indicates that the association may be explained by shared familial confounding. Using
co-relative control analysis, Kendler and colleagues reported that lower cognitive functioning
in schizophrenia and ONAP is unlikely to be explained by familial confounding. Furthermore,
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premorbid cognitive deficits in psychosis may be the result of
unique environmental factors (Kendler et al. 2015, 2016a, b).
These findings provide important insights into potential causal
models of psychosis and warrant exploration of unique environ-
mental factors that may contribute to lower cognitive functioning
in psychosis.
Emerging evidence indicates a role for low-grade inflammation
in the pathogenesis of psychotic disorders (Khandaker & Dantzer,
2015; Khandaker et al. 2015a, 2017a). Concentrations of circulat-
ing inflammatory markers such as interleukin 6 (IL-6) and
C-reactive protein (CRP) are elevated during acute psychotic epi-
sodes, which tend to normalise after recovery but continue to be
elevated in treatment-resistant patients (Potvin et al. 2008; Miller
et al. 2011; Goldsmith et al. 2016). Elevated serum concentrations
of IL-6 and CRP in childhood/ adolescence are associated with
increased risks of psychotic symptoms or diagnosis of schizophre-
nia subsequently in adulthood (Khandaker et al. 2014; Metcalf
et al. 2017), which indicates that reverse causality is an unlikely
explanation for the observed association between low-grade
inflammation and psychosis. A functional genetic variant in the
IL-6R gene known to dampen down inflammation (Ferreira
et al. 2013) is protective for psychosis and/or severe depression
(Khandaker et al. 2017b) and physical illness commonly
comorbid with psychosis such as coronary heart disease (IL6R
Genetics Consortium & Emerging Risk Factors Collaboration,
2012) as shown using Mendelian randomisation. This suggests
that the inflammation–psychosis relationship is unlikely to be
explained by confounding fully.
Despite a great deal of cross-sectional case-control studies link-
ing low-grade inflammationwith psychosis (Goldsmith et al. 2016),
population-based longitudinal studies are relatively rare (Gardner
et al. 2013; Wium-Andersen et al. 2013; Khandaker et al. 2014;
Metcalf et al. 2017). To our knowledge, no longitudinal study has
examined the association between erythrocyte sedimentation rate
(ESR), a surrogate marker of systemic inflammation and particu-
larly acute phase reaction (Harrison, 2015), and subsequent risk
of schizophrenia and related psychosis.
Low-grade inflammation can influence cognitive function
across the life-course in the healthy population and in people
with schizophrenia. We have reported that elevated CRP is asso-
ciated with lower IQ in childhood in the ALSPAC birth cohort
(MacKinnon et al. 2017). We have also reported that there is an
inverse relationship between ESR and IQ based on a sample of
healthy Swedish adolescents/young-adults (Karlsson et al. 2010).
Similarly, higher levels of CRP are associated with a lower cogni-
tive function in patients with schizophrenia (Dickerson et al.
2007). It is plausible that low-grade inflammation influences
psychosis risk by affecting neurodevelopment. However, studies
examining whether IQ mediates and/or moderates the association
between ESR and subsequent psychotic disorders or whether they
are independent risk factors are scarce.
The present study aimed to examine the relationship between
inflammation (indexed by ESR), neurodevelopment (indexed by
IQ), and subsequent risk of hospitalisation with non-affective
psychoses in adulthood in a Swedish population-based sample
of 638 213 male conscripts. First, we examine the relationships
between lower cognitive functioning at 18–20 years and subse-
quent diagnosis of psychoses (Jones et al. 1994; Zammit et al.
2004; Khandaker et al. 2011; Kendler et al. 2015). Second, we
examine the association between inflammation and IQ reported
previously from our smaller population-based Swedish sample
(Karlsson et al. 2010). Third, we test the relationship between
inflammation and subsequent diagnosis of psychotic illness. In
addition, we examine whether the ESR-psychoses relationship
and ESR-IQ association could be explained by shared familial fac-
tors using co-relative analysis. We examine mediation and mod-
eration between ESR and IQ with regards to risk of psychoses.
Materials and methods
Study population and diagnosis of psychosis
Thepresent study is based on Swedishmen conscripted intomilitary
between 1969 and 1983. In Sweden, all men underwent obligatory
military conscription between ages 18 and 20 years bar certain
exceptions, so this representative sample included approximately
97% of the male population (Karlsson et al. 2010). The conscripts
underwent various assessments over 2 days that tested their suitabil-
ity for military service. The data provide a unique opportunity for
epidemiological investigations; see Ahlborg et al. (1973). The con-
scription data were linked to the Swedish National Hospital
Discharge Register until end of 2011, resulting in an average
follow-up period of 35 years (range: 21–42 years) after conscription
(mean age at follow-up: 54 years; range: 45–68 years). The discharge
register contains medical diagnoses defined by the International
Classification of Diseases (ICD; World Health Organization,
2004). This allowed the identification of individuals first hospitalised
with a discharge diagnosis of schizophrenia (ICD-10: F20; ICD-9
and ICD-8: 295) or ONAP (ICD-10: F21 = Schizotypal Disorder,
F22 = Persistent Delusional Disorder, F23 = Acute and Transient
Psychotic Disorders, F24 = Induced Delusional Disorder, F25 =
Schizoaffective Disorder, F28 = Other Non-organic Psychotic
Disorders, F29 = Unspecified Non-organic Psychosis; correspond-
ing diagnostic codes in ICD-9: 297, 298.2-9, 291.3, 291.5, 292.1;
ICD-8: 297.0-9, 298.2-3, 298.9, 291.2-3). See online Supplementary
Fig. 1 for sample selection process.
Measurements of IQ and ESR
Intelligence was measured during military conscription by tests
on logic/general intelligence, verbal intelligence, visuospatial per-
ception, and mechanical skills in solving mathematical or physical
problems; see Karlsson et al. (2010). Results of these tests were
aggregated on a nine-point scale that approximately corresponds
to Wechsler adult IQ bands <74, 74–81, 82–89, 90–95, 96–104,
105–110, 111–118, 119–126, and >126. For visibility and com-
parison purposes, we rescaled IQ scores from this 9-point scale
to a continuous score with mean = 100 (SD = 15).
ESR was measured from venous blood samples taken at con-
scription. ESR is the rate of sedimentation of red blood cells mea-
sured over an hour and is a marker of inflammation, particularly a
surrogate marker of acute phase reaction (Harrison, 2015). As
with our previous Swedish study (Karlsson et al. 2010), ESR
was corrected for the erythrocyte volume in the blood (i.e. haem-
atocrit), according to the formula ESR × (haematocrit /45), and
grouped into four bands, 0–3, 4–6, 7–10, and ⩾11 mm/h. The dis-
tribution of ESR was skewed (mean = 3.38; median = 2.18; IQR =
1.87–4.00), so this categorisation allowed better investigation of
the effect of high ESR levels on IQ/psychosis. In addition, we car-
ried out sensitivity analyses: (1) by grouping ESR into quartiles;
(2) by grouping ESR into deciles; (3) using ESR as a continuous
variable; and (4) after excluding participants with very high ESR
that may be indicative of an infection; according to Mayo clinic,
in men ESR>22 mm/h indicates acute infection.
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Covariates
Migration status (either/both parents born outside Sweden), win-
ter birth (December–May), parental history of schizophrenia and/
or ONAP, household crowding, and maximum parental socio-
economic status at child’s age of 8–12 years (worker, white collar
professional, business owner, and unknown) were included as
covariates.
Statistical analysis
First, to analyse the association of IQ and ESR with schizophrenia
or ONAP, Cox regression was used to estimate hazard ratios (HRs)
and 95% confidence intervals (CIs) for each one-point increase in
IQ (and separately, for individuals in the higher ESR bands com-
pared with ESR band 0–3 mm/h). Further analyses were carried
out adjusting for potential confounders, and after excluding 622
participants hospitalised within 2 years of conscription to minim-
ise reverse causality. Second, we performed co-relative analyses to
determine whether HRs for the association between ESR and
schizophrenia or ONAP changed as a function of family related-
ness. To this end, we applied stratified Cox regression models on
respective outcomes in the general population, cousin, half-sibling,
and full-sibling pairs. For analyses of relative pairs, robust standard
errors were calculated to adjust for family relatedness, that is, we
included a cluster effect of each family pair. Furthermore, relative
pairs falling into equal ESR bands were excluded to allow identifia-
bility/convergence of the statistical model. We tested the propor-
tionality assumption across all models. We also performed
co-relative analyses of the ESR-IQ association. Due to the continu-
ous outcome variable and cross-sectional association, we estimated
linear mixed-effects models with outcome IQ and categorical ESR
predictors as before (again excluding relative pairs with equal ESR).
The models included a random intercept for relative pairs to strat-
ify analyses. Third, we tested the association between ESR (pre-
dictor) and IQ (outcome) using linear regression before and after
adjusting for potential confounders.
Fourth, we tested whether IQ mediated or moderated the rela-
tionship between ESR and schizophrenia or ONAP. For these
analyses, we used logistic and linear regression models. We tested
mediation by calculating direct and indirect effects of ESR on
psychoses. Mediation analysis of the ESR-psychoses relationship
by IQ was not conducted for outcome schizophrenia as the
unadjusted main analysis did not reach statistical significance,
which is a prerequisite for testing mediation. However, mediation
analysis for the outcome of ONAP was conducted using the sub-
groups of individuals with ESR of 0–3 mm/h or 7–10 mm/h, in
which main analyses had shown an association between ESR
and psychosis. We were also able to run mediation analyses of
these ESR groups for both schizophrenia and ONAP when adjusting
for covariates. Moderation was tested by including an interaction
term (IQxESR) in logistic regression models of schizophrenia and
ONAP.
Results
Baseline characteristics
Of the total sample of 638 213 Swedish men, at baseline 470 923
(73.79%) had an ESR level of 0–3 mm/h, 112 089 (17.56%) of
4–6 mm/h, 35 023 (5.49%) of 7–10 mm/h, and 20 178 (3.16%)
of ⩾11 mm/h. ESR groups differed significantly in age at con-
scription, migration status, winter birth, parental socioeconomic
status, and household crowding (all p < 0.05; Table 1). In total,
5398 (0.85%) and 5133 (0.80%) individuals in this population-
based sample developed schizophrenia or ONAP until follow-up,
respectively.
Associations between IQ, schizophrenia, and ONAP
With each one-point increase in IQ, risk decreased for schizo-
phrenia (unadjusted HR = 0.963, 95% CI 0.961–0.964; adjusted
HR = 0.961, 95% CI 0.960–0.963), and for ONAP (unadjusted
HR = 0.974; 95% CI 0.972–0.976; adjusted HR = 0.973, 95% CI
0.971–0.975). Evidence for these associations remained after
excluding individuals hospitalised within 2 years after conscrip-
tion (online Supplementary Table 1).
Association between ESR and IQ
Higher ESR was associated with lower IQ at the time of conscrip-
tion in a dose-response function (Table 2). When compared with
ESR of 0–3 mm/h, there was a small but robust decrease in IQ for
groups with higher ESR levels. After adjusting for potential con-
founders these associations attenuated, but remained significant.
We explored whether the dose–response relationship observed
using ESR as a categorical variable could be more parsimoniously
explained using ESR as a continuous variable. Comparing these
models using a log-likelihood test revealed no significant differ-
ence between two models ( p = 0.62) suggesting that categorical
classification of ESR is not superior to a linear description of
the ESR-IQ association (online Supplementary Table 2).
Associations between ESR, schizophrenia, and ONAP
The risk of future hospitalisation with schizophrenia was higher
in the group with ESR of 7–10 mm/h at baseline, compared
with 0–3 mm/h, although this association only reached statistical
significance after adjusting for confounding variables (see Table 3;
Figure 1; online Supplementary Table 3). Conversely, the risk for
ONAP was significantly lower in the group with ESR of 7–10 mm/h,
compared with 0–3 mm/h, both before and after adjusting for con-
founders. There were no significant differences between ESR bands
of 4–6 mm/h and ⩾11 mm/h as compared with the reference group
(0–3 mm/h). Exclusion of prodromal cases did not change the pat-
tern of results.
Co-relative control analysis of the ESR-psychoses association
The HRs for schizophrenia and ONAP for the group with ESR
levels 7–10 mm/h, compared with 0–3 mm/h, was similar for
the general population and full-sibling pairs (who share on aver-
age 50% of their genomes and presumably the largest number of
environmental factors among the investigated groups of
co-relatives): higher ESR increased risk of schizophrenia, but
decreased risk of ONAP (Table 4). The results offer some support
that these specific ESR and psychoses relationships may not be
fully confounded by shared familial factors.
Co-relative control analysis of the ESR-IQ association
Co-relative control analysis of the ESR-IQ association, using linear
mixed-effects regression and a random intercept for relative pairs,
showed evidence of familial confounding (online Supplementary
Table 4). The mean difference in IQ for higher ESR levels
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(compared with ESR 0–3 mm/h) were between 0.5 and 1.5 IQ
points in the general population (ESR 4–6 mm/h = −0.48, 95% CI
−0.58 to −0.38; ESR 7–10 mm/h = −0.95, 95% CI −1.12 to −0.79;
ESR ⩾11 mm/h =−1.57, 95% CI −1.78 to −1.36). However, this
difference markedly decreased in a gradual manner with increasing
family relatedness (results for full-sibling pairs: ESR 4–6 mm/h =
−0.02, 95% CI −0.17 to 0.14; ESR 7–10 mm/h =−0.21, 95% CI
−0.44 to 0.03; ESR ⩾11 mm/h = −0.68, 95% CI −0.98 to −0.38.
Mediation and moderation of the ESR and psychoses
association by IQ
We testedwhether IQmediated the association of ESR (7–10 mm/h)
with schizophrenia andONAP. For schizophrenia, the indirect effect
(mediated by IQ)was significant in the adjustedmodel (β = 0.004, SE
< 0.001, p < 0.001). Similarly, for ONAP, the indirect effect was sig-
nificant in both unadjusted (β = 0.003, SE < 0.001, p < 0.001) and
adjusted models (β = 0.003, SE < 0.001, p < 0.001; see online
Supplementary Table 5 and online Supplementary Fig. 2).
However, there was no evidence for an interaction between ESR
and IQ on regression models for schizophrenia or ONAP (online
Supplementary Table 6).
Sensitivity analyses of ESR and psychoses association
We re-examined the ESR-psychosis association using ESR as a
continuous variable, using ESR quartiles, and using ESR deciles
before and after excluding participants with a suspected acute
infection (ESR >22 mm/h). After adjusting for potential confoun-
ders and excluding both potentially prodromal cases of psychosis
and those with suspected infection, there was trend level associ-
ation indicating that each one-point increase in ESR increased
the risk of schizophrenia ( p = 0.070), but decreased the risk of
ONAP ( p = 0.053); see online Supplementary Table 7.
Table 1. Baseline characteristics of the sample
Characteristic All participants
Groups based on ESR Levels at Conscription in mm/h
0–3 4–6 7–10 ⩾11 p Valuea
Sample size, N (% of total) 638 213 470 923 (73.79) 112 089 (17.56) 35 023 (5.49) 20 178 (3.16) −
ESR, M (SD) 3.38 (3.32) 2.05 (0.85) 5.00 (0.83) 8.45 (1.14) 16.70 (6.94) <0.001
IQ at conscription, M (SD) 100.00 (15.00) 100.20 (15.00) 99.71 (14.96) 99.23 (15.04) 98.61 (14.98) <0.001
Age at conscription, M (SD) 18.38 (0.75) 18.38 (0.75) 18.37 (0.75) 18.39 (0.74) 18.40 (0.71) <0.001
Age at end of follow-up, M (SD) 53.76 (4.26) 53.72 (4.32) 53.73 (4.05) 53.99 (4.11) 54.38 (4.17) <0.001
Parental history of psychoses, N (%) 17 161 (2.69) 12 698 (2.70) 2991 (2.67) 923 (2.64) 549 (2.72) 0.863
Migration Status, N (%) 95 318 (14.94) 71 284 (15.14) 16 174 (14.43) 4940 (14.11) 2920 (14.47) <0.001
Winter birth, N (%) 330 651 (51.81) 243 609 (51.73) 58 136 (51.87) 18 295 (52.24) 10 611 (52.59) 0.032
Parental socioeconomic status at age 8–12 years
Worker, N (%) 235 705 (36.93) 171 820 (36.49) 42 107 (37.57) 13 572 (38.75) 8206 (40.67)
White collar, N (%) 263 805 (41.33) 197 830 (42.01) 45 154 (40.28) 13 465 (38.45) 7356 (36.46)
Own business, N (%) 104 999 (16.45) 76 390 (16.22) 18 928 (16.89) 6146 (17.55) 3555 (17.62)
Unknown, N (%) 33 704 (5.28) 24 903 (5.29) 5900 (5.26) 1840 (5.25) 1061 (5.26) <0.001
Household Crowding
Overcrowded, N (%) 180 539 (28.29) 130 274 (27.66) 33 368 (29.77) 10 582 (30.21) 6315 (31.30)
Not overcrowded, N (%) 448 877 (70.33) 334 097 (70.95) 77 188 (68.86) 23 973 (68.45) 13 619 (67.49)
Unknown, N (%) 8797 (1.38) 6552 (1.39) 1533 (1.37) 468 (1.34) 244 (1.21) <0.001
ap values are based on ANOVA tests for continuous and χ2 tests for categorical variables.
Table 2. Association between ESR and IQ at age 18 years
ESR (mm/h) at 18–20 years No. Mean IQ at 18–20 years (SD)
Mean difference [95% CI]a
Unadjusted p Value Adjustedb p Value
0–3 470 923 100.20 (15.00) Reference − Reference −
4–6 112 089 99.71 (14.96) −0.48 [−0.58, −0.38] <0.001 −0.30 [−0.39, −0.20] <0.001
7–10 35 023 99.23 (15.04) −0.95 [−1.12, −0.79] <0.001 −0.64 [−0.80, −0.49] <0.001
⩾11 20 178 98.61 (14.98) −1.57 [−1.78, −1.36] <0.001 −1.08 [−1.28, −0.88] <0.001
aThe mean difference was calculated using the group with ESR = 0–3 mm/h as a reference.
bRegression models were adjusted for household crowding, winter birth, parental socioeconomic status at 8–12 years, migration status, and parental history of non-affective psychoses.
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Using ESR as quartiles, there was no association with schizo-
phrenia (online Supplementary Table 8). However, those in the
3rd quartile of ESR had an increased risk of ONAP compared
with 1st quartile; unadjusted HR 1.09 (95% CI, 1.01, 1.17); p =
0.029; evidence for this association attenuated after adjusting for
potential confounders and exclusions ( p = 0.074) (online
Supplementary Table 9).
After adjusting for potential confounders and exclusions, there
was a trend level association indicating that those in the top decile
ofESR, comparedwithbottomdecile, had an increased riskof schizo-
phrenia (HR = 1.12; 95% CI, 1.00, 1.27); p = 0.056 (online
Supplementary Table 10), but decreased risk of ONAP (HR = 0.89;
95% CI, 0.78, 1.01); p = 0.074 (online Supplementary Table 11).
Discussion
The present study investigated potential roles of inflammation
and neurodevelopment in the pathogenesis of psychotic disorders
in a large Swedish population-based male sample. We showed
that lower IQ is robustly associated with subsequent diagnoses
of schizophrenia and ONAP. We also observed a cross-sectional
association between ESR and IQ that followed a linear pattern;
co-relative control analyses showed this association was partly
due to familial factors. There was some, albeit weak, evidence
for an association between ESR and increased risk for schizophre-
nia. Contrary to our hypotheses, higher ESR was associated with
decreased risk for ONAP. Co-relative control analyses suggested
that respective associations between ESR and subsequent risk of
psychosis might not be explained fully by shared familial factors.
With regard to the interplay between inflammation and neurode-
velopment, there was some evidence that IQ partly mediated the
association between ESR and psychotic disorders. There was no
evidence for interaction between ESR and IQ with regard to the
risk of psychoses.
The association between premorbid IQ and psychotic disor-
ders has been studied extensively. Our findings are consistent
with previous studies reporting lower premorbid IQ in future
patients of schizophrenia and ONAP (Jones et al. 1994; Crow
et al. 1995; David et al. 1997; Davidson et al. 1999; Cannon
et al. 2000, 2002; Zammit et al. 2004; Reichenberg et al. 2005;
Kendler et al. 2015). Adjusting for potential confounders and
exclusion of suspected prodromal cases had minimal impact on
this association. Previous studies indicate unique environmental
factors may contribute to lower premorbid IQ in psychotic disor-
ders (Kendler et al. 2015, 2016a). Our work indicates that low-
grade inflammation may be one such factor.
We have presented separate analyses for schizophrenia and
ONAP to cover the entire spectrum of psychotic disorders. In
young people, diagnosis can change over time, e.g. from other
NAP to schizophrenia (Fusar-Poli et al. 2016). Longitudinal stud-
ies have reported that lower premorbid IQ (Kendler et al. 2016b),
prenatal/ childhood infections (Brown et al. 2004; Dalman et al.
2008; Blomstrom et al. 2016) are associated with schizophrenia
and ONAP suggesting impaired neurodevelopment and
immune-related risk factors are relevant for all of these disorders.
The results for an association between ESR and IQ are consist-
ent with our previous Swedish population-based study based on a
smaller sample of 49 321 participants (Karlsson et al. 2010). The
findings indicate that low-grade systemic inflammation, as
indexed by ESR, might affect cognitive development/functioning.
However, the cross-sectional nature of the ESR-IQ association
means that reverse causality cannot be excluded (Luciano et al.Ta
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2009). In future, longitudinal studies are required. Cognitive
impairments associated with acute inflammatory conditions
observed in experimental studies of humans and animals may
be part of a ‘sickness response’, which is mediated by effector
molecules such as cytokines (Reichenberg et al. 2001). Chronic
low-grade inflammation, as indexed by elevated concentrations
of inflammatory markers, has also been associated with cognitive
impairments in elderly individuals (Gorelick, 2010) and with
lower IQ in children (MacKinnon et al. 2017). In the elderly,
such effects may involve vascular changes in the brain paren-
chyma induced by subtle but chronic elevations in inflammatory
mediators associated with aging and other factors (Casserly &
Topol, 2004). In children, however, potential mechanisms are
less clear, and might involve effects of inflammatory cytokines
on brain development and functioning (Spencer et al. 2005;
Asp et al. 2009; McAfoose & Baune, 2009; Liu et al. 2014;
Khandaker & Dantzer, 2015).
Low-grade inflammation had an opposing effect on different
types of psychotic disorders; higher ESR increased the risk of
schizophrenia but decreased the risk of ONAP. A Previous
study has shown that higher levels of IL-6 at age 9 are associated
with increased risk for psychotic symptoms at 18 years
(Khandaker et al. 2014). Other studies have reported an associ-
ation between higher levels of CRP at baseline and subsequent
risk for schizophrenia at follow-up (Wium-Andersen et al.
2013; Metcalf et al. 2017). These findings are consistent with
our results that ESR levels in the upper normal range are asso-
ciated with increased risk for schizophrenia. Protective effect of
high ESR for ONAP in our sample might be due to diverse diag-
noses included in this group. In a Finnish longitudinal cohort
study higher CRP in adolescence was associated with increased
risk of schizophrenia, but not ONAP, in adulthood (Metcalf
et al. 2017). We previously reported an association between
lower concentrations of acute phase proteins in neonatal blood
spots and diagnosis of non-affective psychosis including schizo-
phrenia in adulthood; but did not have power to examine schizo-
phrenia and other psychosis separately (Gardner et al. 2013).
Taken together, the current studies indicate that low-grade
inflammation may increase the risk of schizophrenia, but its asso-
ciation with ONAP is less clear, indicating that further studies
looking at specific types of psychoses are required.
Results from co-relative control analyses further refine our
results of the ESR-psychoses and ESR-IQ associations. The associ-
ation between ESR and schizophrenia was comparable between
individuals in the general population and between members of
full-sibling pairs, suggesting that shared familial factors are unlikely
to explain these associations fully. This suggests unique environ-
mental exposures rather than genetic or shared environmental fac-
tors may be important. This is consistent with a Danish
population-based study that reported that polygenic risk scores
for schizophrenia and a history of infections were independent risk-
factors for schizophrenia (Benros et al. 2016). As the results for
cousin and half-sibling pairs were not significant, this analysis
requires replication in a different, possibly even larger sample.
The ESR-IQ association, however, clearly highlighted familial influ-
ence on this association. Population-based studies do suggest that
susceptibility to infection may have a genetic contribution (Cooke
&Hill, 2001; Obel et al. 2010; Hwang et al. 2012), so the association
of systemic inflammation and cognitive functioning might be
largely based on genetic, but also shared environmental factors.
Thus, our findings provide an interesting distinction: the associ-
ation of low-grade inflammation with cognitive functioning
might be due to shared familial factors, but its association with
psychosis may be due to unique, environmental factors.
The results of our mediation analysis indicate that inflamma-
tion may influence the risk of psychosis by affecting neurodeve-
lopment. Thus, immune and neurodevelopmental mechanisms
for pathogenesis of psychosis could be potentially intertwined.
ESR increased the risk for both schizophrenia and ONAP (indir-
ectly via IQ), yet also lowered risk (directly) for ONAP.
Statistically, this phenomenon has been described as suppression
(MacKinnon et al. 2000), in which both risk and protective factors
operate together. Suppression hints towards the presence of differ-
ent, opposing biological pathways, where only the sum of the dir-
ect and indirect effects of a risk factor reflects its final
contribution towards causation of an illness.
Fig. 1. Association between ESR and schizophre-
nia (left), and other non-affective psychoses
(right) (the group with ESR of 0–3 mm/h was
used as the reference for all analyses).
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The results of this study need to be considered in light of its
limitations. ESR is a marker of systemic inflammation and it
represents activation of acute phase response due to various stim-
uli (e.g., infection, cancer). In future, studies of more sensitive and
direct measures of innate immune activity, such as IL-6 or CRP,
might be helpful. We carried out a number of sensitivity analyses
to explore the ESR-psychosis relationships further. There was
some evidence for an association between ESR and schizophrenia
for participants in the top decile of ESR distribution but effects
were not robust. The analyses presented here are based on male
conscripts and might not be generalisable to women. However,
previous studies did not indicate any notable sex difference for
the association between inflammation and cognition
(Khandaker et al. 2015b; Gale et al. 2016), or for the association
between inflammation and psychoses (Khandaker et al. 2014).
Strengths of this study include a large population-based sample
with data from reliable general population registers, long
follow-up period, and innovative co-relative analyses that allowed
exploration of shared familial confounding.
In conclusion, we report that lower IQ is associated with low-
grade inflammation (cross-sectional), and with an increased risk
of psychotic disorders (longitudinal) in adulthood. There is
some evidence that inflammation may increase the risk of schizo-
phrenia by affecting processes involved in cognitive development.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291718000831
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